These signaling pathways could be activated by any number of known secreted growth factors and cytokines from obASCs to upregulate ABCB1. ABCB1 is not known to play a role in the metastatic phenotype of breast cancer but is associated with a more aggressive cancer that is drug resistant leading to worse outcomes. This evidence concerns the gene ABCB1 and cancer.